SEC Company Response from Autolus Therapeutics plc (AUTL) (CIK 0001730463) (AUTL) — Apr 8, 2019
Autolus Therapeutics plc (AUTL) (CIK 0001730463)
Date: April 8, 2019 · CIK: 0001730463 · Accession: 0001193125-19-100812
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-230767
Letter
Autolus Therapeutics plc
Forest House
58 Wood Lane
White City
London W12 7RZ
United Kingdom
VIA EDGAR
April 8, 2019
U.S. Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Attn:
Ms. Mary Beth Breslin
Ms. Christine Westbrook
Re:
Autolus Therapeutics plc
Registration Statement on Form F-1
File No. 333-230767
Acceleration Request
Requested Date: Wednesday, April 10, 2019
Requested Time: 4:30 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 to become effective on April 10, 2019, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the staff. The Registrant hereby authorizes each of Darren DeStefano, Brian Leaf, Courtney Thorne and Katie Kazem of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP at + 1 703 456 8034, or in his absence, Courtney Thorne at + 1 617 937 2318. Thank you for your assistance with this matter.
[Signature Page Follows]
Sincerely,
AUTOLUS THERAPEUTICS PLC
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Autolus Therapeutics plc
Forest House
58 Wood Lane
White City
London W12 7RZ
United Kingdom
VIA EDGAR
April 8, 2019
U.S. Securities
and Exchange Commission
Division of Corporation Finance
100
F Street, N.E.
Washington, D.C. 20549
Attn:
Ms. Mary Beth Breslin
Ms. Christine Westbrook
Re:
Autolus Therapeutics plc
Registration Statement on Form F-1
File No. 333-230767
Acceleration Request
Requested Date: Wednesday, April 10, 2019
Requested Time: 4:30 P.M. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”)
hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form F-1 to
become effective on April 10, 2019, at 4:30 p.m., Eastern Time, or as soon thereafter as is practicable, or at such later time as its counsel may orally request via telephone call to the staff. The Registrant hereby authorizes each of Darren
DeStefano, Brian Leaf, Courtney Thorne and Katie Kazem of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once
the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP at + 1 703 456 8034, or in his absence, Courtney Thorne at + 1 617 937 2318. Thank you for your
assistance with this matter.
[Signature Page Follows]
Sincerely,
AUTOLUS THERAPEUTICS PLC
By:
/s/ Christian Itin
Christian Itin
Chief Executive Officer
cc:
Matthias Alder, Autolus Therapeutics plc
Darren DeStefano, Cooley LLP
Christian Plaza, Cooley LLP
Brian Leaf, Cooley
LLP
Courtney Thorne, Cooley LLP
Katie
Kazem, Cooley LLP